Pharmaceutical Industry discussion, review, analysis, news and information. |
« Plavix®’s Safety in Question | Main | ZoMaxx™ Drug-Eluting Coronary Stent’s First Human Clinical Trial Showed Positive Results »
|
Mar13
|
 The USFDA granted a 510K clearance to Abbott Diabetes Care to market the company’s FreeStyle® Freedom™ blood glucose monitoring system for consumer use.
FreeStyle® Freedom™ requires the smallest blood sample size (0.3 micro liter) among all blood glucose monitoring product on the market. The product offers virtually pain-free testing and provides results in just five seconds.
Read the complete Abbott Press Release. |
TrackBack URL for this entry:
« Plavix®’s Safety in Question | Main | ZoMaxx™ Drug-Eluting Coronary Stent’s First Human Clinical Trial Showed Positive Results »
Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!
BIZZlogos - Add your logo - free link to your site| View Network Map Network Feed List (OPML) Know More Media Network Feed |
PharmaGazette is a member of the Know More Media network of business related blogs.
Here are some current headlines from some of our business publications:
ProductivityGoal | CallCenterScript |
AdHurl | TheBizofKnowledge |
LandingTheDeal | CustomersAreAlways |
HealthCareVox | BrainBasedBusiness |
TheInsurancePolicy | MarketingBlurb |
Write for us About us Contact Advertise Privacy Disclaimer
This weblog is licensed under a Creative Commons License.
Comment Preview